Boostertx
Founded 2020 · 11 employees on LinkedIn · 3 known investors
Find your way into Boostertx
360 people in our graph share verified history with the Boostertx team — schools, employers, funds. One of them is your warm intro.
Ben Robbinsunlockedknows João Ribas · together at Harvard Medical School (overlapped)
×6knows the team · via Freie Universität Berlin
knows the team · via IMD
×2knows the team · via Harvard Medical School
knows the team · via Novo Holdings
knows the team · via Global Biotech Revolution
Booster Therapeutics develops small-molecule medicines that directly activate the cell's 20S proteasome to restore protein quality-control and clear disease-causing proteins, using its structure-based DGRADX platform combining high-throughput screening, X-ray crystallography, and computational tools. The company is building a multi-disease pipeline initially focused on neurodegenerative diseases.
Founders & leadership
Boostertx was founded in 2020 by Diogo R. Feleciano and Darci J. Trader.
DR
Diogo R. FelecianoinCo-Founder & CSODiogo Feleciano co-founded Booster Therapeutics in 2020 and serves as Chief Scientific Officer. He has over a decade of experience in life sciences spanning academic research, venture capital, and biotech, with expertise in R&D, company building, and aging, neurology, and ocular biology.
DJ
Darci J. TraderScientific Co-Founder / Advisor
JR
João RibasinInterim-CBOJoão Ribas is a biotech operator and venture investor who has held board positions and operational roles across multiple therapeutics companies including Asgard Therapeutics, Booster Therapeutics, Orbis Medicines, and Tribune Therapeutics, and currently serves as interim executive at Booster Therapeutics while leading venture creation efforts at BiOrigin.
Investors · 3
Frequently asked questions
- What does Boostertx do?
- Booster Therapeutics develops small-molecule medicines that directly activate the cell's 20S proteasome to restore protein quality-control and clear disease-causing proteins, using its structure-based DGRADX platform combining high-throughput screening, X-ray crystallography, and computational tools. The company is building a multi-disease pipeline initially focused on neurodegenerative diseases.
- Who founded Boostertx?
- Boostertx was founded by Diogo R. Feleciano, Darci J. Trader in 2020.
- Who are Boostertx's investors?
- Boostertx's investors include Apollo Health Ventures, Novo Holdings, Korify Capital.